Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1993 Mar;84(3):304–309. doi: 10.1111/j.1349-7006.1993.tb02871.x

Use of Serum Gamma‐enolase and Aldolase A in Combination as Markers for Renal Cell Carcinoma

Munehisa Takashi 1,✉, Takao Sakata 1, Kanefusa Kato 2
PMCID: PMC5919151  PMID: 8486529

Abstract

To clarify whether measurement of serum γ‐enolase and aldolase A in combination is useful for diagnosis and prediction of prognosis in cases of renal cell carcinoma (RCC), levels of both markers were evaluated by enzyme immunoassay in 132 patients with RCC. Serum γ‐enolase was elevated in 53 of the cases (40%) whereas serum aldolase A was elevated in 45 (34%). At least one of the two markers was elevated in 54% of the patients (71/132), this value being significantly higher than the positive rates for either γ‐enolase (40%) or aldolase A (34%) evaluated singly. Expression of the two markers assessed in combination became more positive with stage progression, values being 37% in stage I, 59% in stage II, 72% in stage III, and 74% in stage IV. In contrast, patients with benign urological diseases demonstrated positive rates for γ‐enolase and aldolase A as low as 3% and 6%, respectively. Increase in serum γ‐enolase was correlated with stage, tumor size, and histological grade, whereas elevated levels of serum aldolase A were associated only with advancing stage. In 15 patients with recurrent diseases, 11 (73%) had elevated levels of γ‐enolase and 5 (33%) had elevated levels of aldolase A, indicating that γ‐enolase is the more sensitive of the two for detection of recurrence. Patients with elevated levels of both γ‐enolase and aldolase A had less favorable survival than those expressing no or only one of the markers, indicating that simultaneous measurement of the two markers provides information directly relevant to prognosis in cases of RCC.

Keywords: Enolase, Aldolase, Isozyme, Renal cell carcinoma, Biomarker

Full Text

The Full Text of this article is available as a PDF (330.9 KB).

REFERENCES

  • 1. ) Rider , C. C. and Taylor , C. B.Enolase isoenzymes in rat tissues: electrophoretic, chromatographic, immunological and kinetic properties . Biochim. Biophys. Acta , 365 , 285 – 300 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Fletcher , L. , Rider , C. C. and Taylor , C. B.Enolase isozymes. III. Chromatographic and immunological characteristics of rat brain enolase . Biochim. Biophys. Acta , 452 , 245 – 252 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Kato , K. , Ishiguro , Y. , Suzuki , F. , Ito , A. and Semba , R.Distribution of nervous system‐specific forms of enolase in peripheral tissues . Brain Res. , 237 , 441 – 448 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Haimoto , H. , Takahashi , Y. , Koshikawa , T. , Nagura , H. and Kato , K.Immunohistochemical localization of γ‐enolase in normal human tissues other than nervous and neuroendocrine tissues . Lab. Invest. , 52 , 257 – 263 ( 1985. ). [PubMed] [Google Scholar]
  • 5. ) Haimoto , H. , Takashi , M. , Koshikawa , T. , Asai , J. and Kato , K.Enolase isozymes in renal tubules and renal cell carcinoma . Am. J. Pathol. , 124 , 488 – 495 ( 1986. ). [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Takashi , M. , Haimoto , H. , Tanaka , J. , Murase , T. and Kato , K.Evaluation of gamma‐enolase as a tumor marker for renal cell carcinoma . J. Urol. , 141 , 830 – 834 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Lebherz , H. G. and Rutter , W. J.Distribution of fructose diphosphate aldolase variants in biological systems . Biochemistry , 8 , 109 – 121 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Penhoet , E. E. and Rutter , W. J.Catalytic and immunochemical properties of homomeric and heteromeric combinations of aldolase subunits . J. Biol. Chem. , 246 , 318 – 323 ( 1971. ). [PubMed] [Google Scholar]
  • 9. ) Asaka , M. , Nagase , K. , Miyazaki , T. and Alpert , E.Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases . Gastroenterology , 84 , 155 – 160 ( 1983. ). [PubMed] [Google Scholar]
  • 10. ) Zhu , Y. , Takashi , M. , Miyake , K. and Kato , K.An immunochemical and immunohistochemical study of aldolase isozymes in renal cell carcinoma . J. Urol. , 146 , 469 – 472 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Takashi , M. , Zhu , Y. , Nakano , Y. , Miyake , K. and Kato , K.Elevated levels of serum aldolase A in patients with renal cell carcinoma . Urol. Res. , 20 , 307 – 311 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Robson , C. J. , Churchill , B. M. and Anderson , W.The results of radical nephrectomy for renal cell carcinoma . J. Urol. , 101 , 297 – 301 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Okajima , K. , Kurobe , N. , Shimizu , K. and Kato , K.Sensitive enzyme immunoassay for human aldolase A . Clin. Chim. Acta , 187 , 265 – 272 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Shimizu , A. , Suzuki , F. and Kato , K.Purification of two enolases from human brain using a chromatofocusing column . Biochim. Biophys. Acta , 717 , 348 – 354 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Penhoet , E. E. , Kochman , M. and Rutter , W. J.Isolation of fructose diphosphate aldolase A, B and C . Biochemistry , 8 , 4391 – 4395 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Kaplan , E. L. and Meier , P.Nonparametric estimation from incomplete observations . J. Am. Stat. Assoc. , 53 , 457 – 481 ( 1958. ). [Google Scholar]
  • 17. ) Gehan , E. A.A generalized Wilcoxon test for comparing arbitrarily single‐censored samples . Biometrika , 52 , 203 – 223 ( 1965. ). [PubMed] [Google Scholar]
  • 18. ) Richards , B. , Robinson , M. R. G. , Pidcock , N. B. and Cooper , E. H.Serum protein profiles in carcinoma of the kidney . Eur. Urol. , 8 , 32 – 36 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Babaian , R. J. and Swanson , D. A.Serum haptoglobin: a nonspecific tumor marker for renal cell carcinoma . South Med. J. , 75 , 1345 – 1348 ( 1982. ). [PubMed] [Google Scholar]
  • 20. ) Sufrin , G. , Mink , I. , Fitzpatrick , J. , Moore , R. and Murphy , G. P.Coagulation factors in renal cell adenocarcinoma . J. Urol. , 119 , 727 – 730 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Selli , C. , Cozzolino , F. , Carini , M. , Lenzi , R. and Vercelli , D.Serum beta 2 microglobulin levels in patients with renal cell carcinoma . Urol. Res. , 12 , 261 – 263 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Baumann , M. , Lang , T. and Brand , K.Phosphohexose isomerase in hypernephroma: significance as serum tumor marker, comparison to other glycolytic enzymes and isozyme patterns in normal and tumor tissue . Urol. Res. , 16 , 345 – 349 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Hershman , M. J. , Habib , N. A. , Ferro , M. A. , Williamson , R. C. N. and Wood , C. B.The use of CA‐50 radioimmunoassay test in diagnosis of urologic malignancy . Am. Surg. , 53 , 691 – 694 ( 1987. ). [PubMed] [Google Scholar]
  • 24. ) Takashi , M. , Zhu , Y. , Hasegawa , S. , Miyake , K. , Takagi , Y. and Kato , K.Evaluation of the alpha subunit of S100 protein in sera as a tumor marker for renal cell carcinoma . Jpn. J. Clin. Urol. , 44 , 1055 – 1059 ( 1990. ). [Google Scholar]
  • 25. ) Takashi , M. , Zhu , Y. , Hasegawa , S. and Kato , K.Serum creatine kinase B subunit in patients with renal cell carcinoma . Urol. Int. , 48 , 144 – 148 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Warburg , O. and Minami , S.Versuche an überlebendem Carcinomgewebe . Klin. Wochenschr. , 2 , 776 – 777 ( 1923. ). [Google Scholar]
  • 27. ) Takashi , M. , Haimoto , H. , Nagai , T. , Koshikawa , T. and Kato , K.Enolase isozymes in seminoma . Urol. Res. , 18 , 175 – 180 ( 1990. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES